Needle-Free Subcutaneous Sumatriptan: In the Acute Treatment of Migraine Attacks or Cluster Headache Episodes

CNS Drugs | November 15, 2011

Frampton JE – Although the overall adverse event profile of the needle–free delivery system was similar to that previously reported for the needle–based delivery system, it was associated with a numerically higher incidence of administration/injection–site reactions in clinical trials that enrolled healthy adult volunteers.

Read the full article on CNS Drugs